## ACT: Enact Holdings, Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_20 2.5% below STRENGTH zone (4.0-10.0%); PEG unavailable fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.5% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($37.53)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 1
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. JPMorgan Retains Neutral Stance on Enact (ACT) Despite Minor Target Trim**
- Source: Insider Monkey | 20251201T194900 | Neutral | Relevance: 99%
- JPMorgan's Richard Shane has reaffirmed a Neutral rating for Enact Holdings, Inc. (NASDAQ:ACT) while slightly lowering the price target from $40 to $39. This decision follows the company's third-quarter update, where it reported $311.4 million in total revenue and $14 billion in new insurance written, an increase from the previous quarter and year. Enact Holdings continues to focus on shareholder returns, distributing $31 million in dividends during the period.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 5 ($102.59M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 13.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 2 |

**Top Holders:**
- Blackrock Inc.: 3.2% (+1.0%)
- Vanguard Group Inc: 2.2% (-2.0%)
- Dimensional Fund Adv: 1.9% (+7.1%)
- First Trust Advisors: 1.0% (+87.9%)
- Qube Research & Tech: 1.0% (+289.4%)

### Key Risks

1. Heavy insider selling: $103M sold (5 transactions in 90 days).
2. High short interest (16.6%, 12.5 days to cover): squeeze risk or crowded bearish bet.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

Forward P/E 8.4x stretched relative to 3% growth. Quality metrics strong (margin 54%). Balance sheet: strong liquidity (6612078000.0x), low leverage (D/E 0.29). Insider selling cluster ($102.6M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $5.8B |
| Beta | 0.52 |
| 52W Range | $30.79 - $39.47 |
| Short Interest | 16.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | N/A |
| Forward P/E | 8.4 |
| Current P/E | 8.7 |
| YoY Growth | 3.5% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 5.0% to 2.5% (-2.5% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 1.5pp (needs >4.0% for momentum thesis). MRS_5 (-0.2%) diverging from MRS_20 - short-term weakness emerging. AM_20 at 3.6% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 2.48% (CS: 76) | Neutral |
| RSI_14 | 64.5 | Neutral |
| MACD Histogram | 0.16 | Bullish |
| vs SMA20 | 1.035x | Above |
| vs SMA50 | 1.052x | Above |
| vs SMA200 | 1.081x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $38.93
- **Stop Loss:** $37.53 (3.6% risk)
- **Target:** $40.33 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 714
- **Position Value:** $27,796.02
- **Portfolio %:** 27.80%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

### Earnings

**Next:** 2026-02-04 (Est: $1.10)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.11 | $1.12 | +0.9% |
| 2025Q2 | $1.11 | $1.15 | +3.9% |
| 2025Q1 | $1.09 | $1.10 | +0.9% |
| 2024Q4 | $1.08 | $1.09 | +0.7% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*